ArticleBiomolecules2025

Aptamer Development for SARS-CoV-2 and Omicron Variants Using the Spike Protein Receptor Binding Domain as a Potential Diagnostic Tool and Therapeutic Agent.

Prasanna V Shekar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.